论文部分内容阅读
目的观察沐舒坦氧驱动雾化吸入佐治毛细支气管炎化痰的疗效观察。方法将确诊毛细支气管炎患儿160例随机分为治疗组80例和对照组80例,两组均在常规治疗(抗菌抗病毒,激素、解痉平喘)的基础上,治疗组给予沐舒坦(15mg/次,2次/d)氧驱动雾化吸入,对照组给予常规雾化(地塞米松2mg,庆大霉素4万U,α-糜蛋白酶5mg)超声雾化治疗。观察2组症状、体征、消失时间及疗效。结果治疗组症状、体征、消失时间比对照组明显缩短,差异有统计学意义(P<0.05)。结论沐舒坦氧驱动雾化吸入治疗毛细支气管炎,可明显改善呼吸道症状,疗效显著,局部治疗,不良反应小,值得临床推广。
Objective To observe the curative effect of mucosolvan by aerosol inhalation on treating bronchiolitis and phlegm. Methods One hundred and sixty children with bronchiolitis were randomly divided into treatment group (n = 80) and control group (n = 80). The two groups were given routine treatment (antimicrobial, antiviral, hormonal, antispasmodic and antiasthmatic) / Times, 2 times / d) aerosol inhalation inhalation, the control group given conventional atomization (dexamethasone 2mg, gentamicin 40,000 U, α-chymotrypsin 5mg) ultrasonic atomization treatment. Two groups of symptoms, signs, disappearance time and curative effect were observed. Results The symptoms, signs and disappearance of the treatment group were significantly shorter than those of the control group (P <0.05). Conclusion Mucosal infusion of aerosol inhalation treatment of bronchiolitis, can significantly improve the respiratory symptoms, significant effect, local treatment, adverse reactions, worthy of clinical promotion.